Early awareness and alert system in Sweden: history and current status

Irene Eriksson, Björn Wettermark, Marie Persson, Morgan Edström, Brian Godman, Anna Lindhé, Rickard Malmström, Helena Ramström, Mia von Euler, Anna Bergkvist-Christensen

Research output: Contribution to conferenceAbstract

Abstract

Abstract Summary: We describe the evolution and the current state of the Swedish Early Awareness and Alert System for new drugs, a national level EAA system successfully implemented in a country with decentralized health care managed by 21 regions. Our work is of interest to countries already having EAA systems in place as well as for those seeking to establish EAA activities. Introduction: Over the past decades, early awareness and alert (EAA) activities and systems have gained importance and become a key early health technology assessment (HTA) tool. While a pioneer in HTA, Sweden had no national level EAA activities until recently. We describe the evolution and current status of the Swedish EAA System. Methods: This was a historical analysis based on the knowledge and experience of the authors supplemented by a targeted review of published and grey literature as well as documents produced by or relating to the Swedish EAA System. Key milestones and a description of the current state of the Swedish EAA System is presented. Results: Initiatives to establish a system for the identification and assessment of emerging health technologies in Sweden date back to the 1980s. Since the 90s, the Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) supported the development of EuroScan and was one of its founder members. In the mid-00s, an independent regional initiative, driven by the Stockholm Drug and Therapeutics Committee, resulted in the establishment of a regional horizon scanning unit. By 2009, this work had expanded to a collaboration between the four biggest regions in Sweden. The following year it was further expanded to the national level. Today, the Swedish EAA System carries out identification, filtration and prioritization of new drugs, early assessment of the prioritized drugs, and dissemination of the information. Its outputs are used to select new drugs for inclusion in the Swedish national process for managed introduction and follow-up. Conclusions: The Swedish EAA System started as a regional initiative and rapidly grew to become a national level activity. An important feature of the System today is its complete integration into the national process for managed introduction and follow-up of new drugs. The System will continue to evolve as a response both to the changing landscape of health innovations and to new policy initiatives at the regional, national and international levels.
LanguageEnglish
Number of pages2
Publication statusAccepted/In press - 6 Mar 2017
EventHTAi’s 14th Annual Meeting - Rome, Italy
Duration: 17 Jun 201721 Jun 2017
Conference number: 14th

Conference

ConferenceHTAi’s 14th Annual Meeting
Abbreviated titleHTAiRome2017
CountryItaly
CityRome
Period17/06/1721/06/17

Fingerprint

Biomedical Technology Assessment
Sweden
History
Pharmacy and Therapeutics Committee
Pharmaceutical Preparations
Literature
Information Dissemination
Social Work
Delivery of Health Care
Health

Keywords

  • health technology assessment
  • early awareness and alert system
  • EAA system
  • Sweden

Cite this

Eriksson, I., Wettermark, B., Persson, M., Edström, M., Godman, B., Lindhé, A., ... Bergkvist-Christensen, A. (Accepted/In press). Early awareness and alert system in Sweden: history and current status. Abstract from HTAi’s 14th Annual Meeting, Rome, Italy.
Eriksson, Irene ; Wettermark, Björn ; Persson, Marie ; Edström, Morgan ; Godman, Brian ; Lindhé, Anna ; Malmström, Rickard ; Ramström, Helena ; von Euler, Mia ; Bergkvist-Christensen, Anna. / Early awareness and alert system in Sweden : history and current status. Abstract from HTAi’s 14th Annual Meeting, Rome, Italy.2 p.
@conference{6daf3526f511490ca79f628ca48832e7,
title = "Early awareness and alert system in Sweden: history and current status",
abstract = "Abstract Summary: We describe the evolution and the current state of the Swedish Early Awareness and Alert System for new drugs, a national level EAA system successfully implemented in a country with decentralized health care managed by 21 regions. Our work is of interest to countries already having EAA systems in place as well as for those seeking to establish EAA activities. Introduction: Over the past decades, early awareness and alert (EAA) activities and systems have gained importance and become a key early health technology assessment (HTA) tool. While a pioneer in HTA, Sweden had no national level EAA activities until recently. We describe the evolution and current status of the Swedish EAA System. Methods: This was a historical analysis based on the knowledge and experience of the authors supplemented by a targeted review of published and grey literature as well as documents produced by or relating to the Swedish EAA System. Key milestones and a description of the current state of the Swedish EAA System is presented. Results: Initiatives to establish a system for the identification and assessment of emerging health technologies in Sweden date back to the 1980s. Since the 90s, the Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) supported the development of EuroScan and was one of its founder members. In the mid-00s, an independent regional initiative, driven by the Stockholm Drug and Therapeutics Committee, resulted in the establishment of a regional horizon scanning unit. By 2009, this work had expanded to a collaboration between the four biggest regions in Sweden. The following year it was further expanded to the national level. Today, the Swedish EAA System carries out identification, filtration and prioritization of new drugs, early assessment of the prioritized drugs, and dissemination of the information. Its outputs are used to select new drugs for inclusion in the Swedish national process for managed introduction and follow-up. Conclusions: The Swedish EAA System started as a regional initiative and rapidly grew to become a national level activity. An important feature of the System today is its complete integration into the national process for managed introduction and follow-up of new drugs. The System will continue to evolve as a response both to the changing landscape of health innovations and to new policy initiatives at the regional, national and international levels.",
keywords = "health technology assessment, early awareness and alert system, EAA system, Sweden",
author = "Irene Eriksson and Bj{\"o}rn Wettermark and Marie Persson and Morgan Edstr{\"o}m and Brian Godman and Anna Lindh{\'e} and Rickard Malmstr{\"o}m and Helena Ramstr{\"o}m and {von Euler}, Mia and Anna Bergkvist-Christensen",
year = "2017",
month = "3",
day = "6",
language = "English",
note = "HTAi’s 14th Annual Meeting, HTAiRome2017 ; Conference date: 17-06-2017 Through 21-06-2017",

}

Eriksson, I, Wettermark, B, Persson, M, Edström, M, Godman, B, Lindhé, A, Malmström, R, Ramström, H, von Euler, M & Bergkvist-Christensen, A 2017, 'Early awareness and alert system in Sweden: history and current status' HTAi’s 14th Annual Meeting, Rome, Italy, 17/06/17 - 21/06/17, .

Early awareness and alert system in Sweden : history and current status. / Eriksson, Irene; Wettermark, Björn; Persson, Marie; Edström, Morgan; Godman, Brian; Lindhé, Anna; Malmström, Rickard; Ramström, Helena; von Euler, Mia; Bergkvist-Christensen, Anna.

2017. Abstract from HTAi’s 14th Annual Meeting, Rome, Italy.

Research output: Contribution to conferenceAbstract

TY - CONF

T1 - Early awareness and alert system in Sweden

T2 - history and current status

AU - Eriksson, Irene

AU - Wettermark, Björn

AU - Persson, Marie

AU - Edström, Morgan

AU - Godman, Brian

AU - Lindhé, Anna

AU - Malmström, Rickard

AU - Ramström, Helena

AU - von Euler, Mia

AU - Bergkvist-Christensen, Anna

PY - 2017/3/6

Y1 - 2017/3/6

N2 - Abstract Summary: We describe the evolution and the current state of the Swedish Early Awareness and Alert System for new drugs, a national level EAA system successfully implemented in a country with decentralized health care managed by 21 regions. Our work is of interest to countries already having EAA systems in place as well as for those seeking to establish EAA activities. Introduction: Over the past decades, early awareness and alert (EAA) activities and systems have gained importance and become a key early health technology assessment (HTA) tool. While a pioneer in HTA, Sweden had no national level EAA activities until recently. We describe the evolution and current status of the Swedish EAA System. Methods: This was a historical analysis based on the knowledge and experience of the authors supplemented by a targeted review of published and grey literature as well as documents produced by or relating to the Swedish EAA System. Key milestones and a description of the current state of the Swedish EAA System is presented. Results: Initiatives to establish a system for the identification and assessment of emerging health technologies in Sweden date back to the 1980s. Since the 90s, the Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) supported the development of EuroScan and was one of its founder members. In the mid-00s, an independent regional initiative, driven by the Stockholm Drug and Therapeutics Committee, resulted in the establishment of a regional horizon scanning unit. By 2009, this work had expanded to a collaboration between the four biggest regions in Sweden. The following year it was further expanded to the national level. Today, the Swedish EAA System carries out identification, filtration and prioritization of new drugs, early assessment of the prioritized drugs, and dissemination of the information. Its outputs are used to select new drugs for inclusion in the Swedish national process for managed introduction and follow-up. Conclusions: The Swedish EAA System started as a regional initiative and rapidly grew to become a national level activity. An important feature of the System today is its complete integration into the national process for managed introduction and follow-up of new drugs. The System will continue to evolve as a response both to the changing landscape of health innovations and to new policy initiatives at the regional, national and international levels.

AB - Abstract Summary: We describe the evolution and the current state of the Swedish Early Awareness and Alert System for new drugs, a national level EAA system successfully implemented in a country with decentralized health care managed by 21 regions. Our work is of interest to countries already having EAA systems in place as well as for those seeking to establish EAA activities. Introduction: Over the past decades, early awareness and alert (EAA) activities and systems have gained importance and become a key early health technology assessment (HTA) tool. While a pioneer in HTA, Sweden had no national level EAA activities until recently. We describe the evolution and current status of the Swedish EAA System. Methods: This was a historical analysis based on the knowledge and experience of the authors supplemented by a targeted review of published and grey literature as well as documents produced by or relating to the Swedish EAA System. Key milestones and a description of the current state of the Swedish EAA System is presented. Results: Initiatives to establish a system for the identification and assessment of emerging health technologies in Sweden date back to the 1980s. Since the 90s, the Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) supported the development of EuroScan and was one of its founder members. In the mid-00s, an independent regional initiative, driven by the Stockholm Drug and Therapeutics Committee, resulted in the establishment of a regional horizon scanning unit. By 2009, this work had expanded to a collaboration between the four biggest regions in Sweden. The following year it was further expanded to the national level. Today, the Swedish EAA System carries out identification, filtration and prioritization of new drugs, early assessment of the prioritized drugs, and dissemination of the information. Its outputs are used to select new drugs for inclusion in the Swedish national process for managed introduction and follow-up. Conclusions: The Swedish EAA System started as a regional initiative and rapidly grew to become a national level activity. An important feature of the System today is its complete integration into the national process for managed introduction and follow-up of new drugs. The System will continue to evolve as a response both to the changing landscape of health innovations and to new policy initiatives at the regional, national and international levels.

KW - health technology assessment

KW - early awareness and alert system

KW - EAA system

KW - Sweden

UR - http://www.htai2017.org/

M3 - Abstract

ER -

Eriksson I, Wettermark B, Persson M, Edström M, Godman B, Lindhé A et al. Early awareness and alert system in Sweden: history and current status. 2017. Abstract from HTAi’s 14th Annual Meeting, Rome, Italy.